A vaccine roll-out for mpox has begun in Africa, with the goal of addressing the increasing rate of infections in some areas, such as the DR Congo. Research is also underway to understand the evolution of the disease, including evidence of silent exposure in some populations. The situation is being closely monitored, with efforts to combat the outbreak potentially informed by experiences with other diseases, including malaria and covid.